Takamoto Takeshi, Sugawara Yasuhiko, Hashimoto Takuya, Shimada Kei, Inoue Kazuto, Maruyama Yoshikazu, Makuuchi Masatoshi
Divisions of Hepato-Biliary-Pancreatic and Liver Transplantation Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
Medicine (Baltimore). 2016 Jul;95(27):e4080. doi: 10.1097/MD.0000000000004080.
The aim of the study is to evaluate the prognostic impact of the extent of submillimeter or zero surgical margin (SubMM) area among the patients who underwent liver resection for colorectal liver metastases (CRLM).The influence of suboptimal margin width of <1 mm on long-term outcome is unclear.A total of 423 liver resections for CRLM were performed at Japanese Red Cross Medical Center between 2007 and 2015. Among them, we identified 235 patients who underwent curative initial liver resection and classified them into 2 groups: R0 (margin: ≥1 mm) and R1 (SubMM). The R1 group was further divided into 2 groups by the extent of SubMM area: small SubMM area (≤4 cm) and broad SubMM area (>4 cm).The median tumor number was 4 (range 1-97), 23% had solitary and 37% had 8 or more number of metastases. With a median follow-up period of 30 months, the overall 1-, 3-, 5-year survival for R0 (n = 72) versus R1 (n = 163) groups were 98.4% vs 87.5%, 75.5% versus 57.1%, and 50.1% versus 36.6%, respectively (P = 0.004). After propensity score analysis allowing for matching the tumor number (<8 vs 8 or more), tumor size, and serum carcinoembryonic antigen level, the DFS and OS were significantly higher in the small SubMM area group (P = 0.024, P = 0.049), respectively.Although wide margins >1 mm should be attempted whenever possible, reducing the extent of SubMM area (≤4 cm) can contribute to better long-term outcome when wide margin is not practicable.
本研究的目的是评估在接受结直肠癌肝转移(CRLM)肝切除的患者中,亚毫米或零手术切缘(SubMM)面积范围对预后的影响。切缘宽度<1 mm的非最佳切缘对长期预后的影响尚不清楚。2007年至2015年期间,日本红十字会医疗中心共进行了423例CRLM肝切除术。其中,我们确定了235例行根治性初次肝切除的患者,并将他们分为2组:R0(切缘:≥1 mm)和R1(SubMM)。R1组根据SubMM面积范围进一步分为2组:小SubMM面积(≤4 cm)和大SubMM面积(>4 cm)。肿瘤数量中位数为4(范围1 - 97),23%为单发转移,37%有8个或更多转移灶。中位随访期为30个月,R0组(n = 72)与R1组(n = 163)的1年、3年、5年总生存率分别为98.4%对87.5%、75.5%对57.1%、50.1%对36.6%(P = 0.004)。在进行倾向评分分析以匹配肿瘤数量(<8个对8个或更多)、肿瘤大小和血清癌胚抗原水平后,小SubMM面积组的无病生存期(DFS)和总生存期(OS)显著更高(P = 0.024,P = 0.049)。尽管应尽可能尝试获得>1 mm的宽切缘,但当无法实现宽切缘时,减小SubMM面积(≤4 cm)有助于获得更好的长期预后。